genetic beta-galactosidase deficiency identification mutations different clinical phenotypes Japanese patients genetic neurological disorder mutations lysosomal acid beta-galactosidase gene phenotypic expression complex infantile juvenile adult form basis age onset rate symptomatic progression severity central nervous system involvement acid beta-galactosidase gene Japanese patients families aim mutations individual patients possible correlation mutations clinical phenotypes Northern studies full-length human beta-galactosidase cDNA mRNA undetectable infantile patients normal quantity size juvenile adult patients distinct missense mutations respective clinical forms small-size samples infantile patient decreased detectable mRNA point mutation Cys infantile patient undetectable mRNA mutation Ter mutation Cys juvenile patients adult patients homozygous point mutation Thr mutations juvenile adult patients alter restriction sites normal gene amendable screening prediction mutations responsible clinical disease expression catalytic activity mutant proteins COS-I cell expression system 